Go Pro
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Presbia PLC stock logo
LENSF
Presbia
$0.02
$0.02
$0.00
▼
$0.19
$257K5.915,650 shsN/A
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
$0.04
$0.10
$0.03
▼
$7.72
$277K1.8667,472 shs103,394 shs
Stagezero Life Sciences Ltd. stock logo
SZLSF
Stagezero Life Sciences
$0.00
$0.00
$0.00
▼
$0.00
$120K-3.98N/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
$0.31
$0.31
$0.25
▼
$12.93
$442K-0.062.28 million shsN/A
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Presbia PLC stock logo
LENSF
Presbia
0.00%0.00%0.00%0.00%0.00%
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
0.00%-7.38%-42.28%-92.93%-99.32%
Stagezero Life Sciences Ltd. stock logo
SZLSF
Stagezero Life Sciences
0.00%0.00%0.00%-80.39%-91.45%
Venus Concept Inc. stock logo
VERO
Venus Concept
0.00%0.00%0.00%0.00%-86.38%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Presbia PLC stock logo
LENSF
Presbia
$0.02
$0.02
$0.00
▼
$0.19
$257K5.915,650 shsN/A
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
$0.04
$0.10
$0.03
▼
$7.72
$277K1.8667,472 shs103,394 shs
Stagezero Life Sciences Ltd. stock logo
SZLSF
Stagezero Life Sciences
$0.00
$0.00
$0.00
▼
$0.00
$120K-3.98N/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
$0.31
$0.31
$0.25
▼
$12.93
$442K-0.062.28 million shsN/A
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Presbia PLC stock logo
LENSF
Presbia
0.00%0.00%0.00%0.00%0.00%
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
0.00%-7.38%-42.28%-92.93%-99.32%
Stagezero Life Sciences Ltd. stock logo
SZLSF
Stagezero Life Sciences
0.00%0.00%0.00%-80.39%-91.45%
Venus Concept Inc. stock logo
VERO
Venus Concept
0.00%0.00%0.00%0.00%-86.38%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Presbia PLC stock logo
LENSF
Presbia
0.00
N/AN/AN/A
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
1.50
ReduceN/AN/A
Stagezero Life Sciences Ltd. stock logo
SZLSF
Stagezero Life Sciences
0.00
N/AN/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Presbia PLC stock logo
LENSF
Presbia
N/AN/AN/AN/AN/AN/A
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
N/AN/AN/AN/A$7.89 per shareN/A
Stagezero Life Sciences Ltd. stock logo
SZLSF
Stagezero Life Sciences
N/AN/AN/AN/AN/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
$58.88M0.01N/AN/A$4.30 per share0.07
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Presbia PLC stock logo
LENSF
Presbia
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
-$63.22M-$6.69N/AN/AN/AN/A-184.13%-112.50%11/17/2026 (Estimated)
Stagezero Life Sciences Ltd. stock logo
SZLSF
Stagezero Life Sciences
N/A-$0.01N/AN/AN/AN/AN/AN/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
-$47M-$48.84N/AN/AN/A-92.76%-1,904.25%-85.22%N/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Presbia PLC stock logo
LENSF
Presbia
N/AN/AN/AN/AN/A
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
N/AN/AN/AN/AN/A
Stagezero Life Sciences Ltd. stock logo
SZLSF
Stagezero Life Sciences
N/AN/AN/AN/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Presbia PLC stock logo
LENSF
Presbia
N/AN/AN/A
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
N/A
4.75
4.75
Stagezero Life Sciences Ltd. stock logo
SZLSF
Stagezero Life Sciences
N/AN/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
1.59
0.90
0.59

Institutional Ownership

CompanyInstitutional Ownership
Presbia PLC stock logo
LENSF
Presbia
N/A
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
47.27%
Stagezero Life Sciences Ltd. stock logo
SZLSF
Stagezero Life Sciences
N/A
Venus Concept Inc. stock logo
VERO
Venus Concept
87.41%

Insider Ownership

CompanyInsider Ownership
Presbia PLC stock logo
LENSF
Presbia
74.20%
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
11.11%
Stagezero Life Sciences Ltd. stock logo
SZLSF
Stagezero Life Sciences
2.54%
Venus Concept Inc. stock logo
VERO
Venus Concept
28.04%
CompanyEmployeesShares OutstandingFree FloatOptionable
Presbia PLC stock logo
LENSF
Presbia
2017.12 millionN/ANot Optionable
Vicarious Surgical Inc. stock logo
RBOT
Vicarious Surgical
2107.12 million5.89 millionNo Data
Stagezero Life Sciences Ltd. stock logo
SZLSF
Stagezero Life Sciences
80123.55 million120.42 millionNot Optionable
Venus Concept Inc. stock logo
VERO
Venus Concept
4101.42 million1.03 millionNot Optionable

Recent News About These Companies

Venus Concept Obtains Exclusive Distribution Rights for the HIRONIC Doublo 2.0 Device in US and Canada
July 28, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/28/3334139/0/en/venus-concept-obtains-exclusive-distribution-rights-for-the-hironic-doublo-2-0-device-in-us-and-canada.html
Venus Concept Announces Senior Management Changes
May 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/13/3294518/0/en/venus-concept-announces-senior-management-changes.html
Venus Concept Announces Completion of Common Stock Sale and Short-Form Merger
April 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/01/3266701/0/en/venus-concept-announces-completion-of-common-stock-sale-and-short-form-merger.html
Venus Concept extends bridge financing and eases covenants
February 3, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/venus-concept-extends-bridge-financing-and-eases-covenants?utm_source=marketbeat.com&utm_medium=referral
Venus Concept stock plummets after announcing Nasdaq delisting plans
January 21, 2026  |  uk.investing.comhttps://uk.investing.com/news/stock-market-news/venus-concept-stock-plummets-after-announcing-nasdaq-delisting-plans-93CH-4463879
Venus Concept to exit NASDAQ and end SEC reporting obligations
January 21, 2026  |  msn.comhttps://www.msn.com/en-us/money/companies/venus-concept-to-exit-nasdaq-and-end-sec-reporting-obligations/ar-AA1UEWcO
Venus Concept to Voluntarily Delist and Deregister Shares
January 21, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/venus-concept-to-voluntarily-delist-and-deregister-shares?utm_source=marketbeat.com&utm_medium=referral
Venus Concept Inc. Announces Voluntary Delisting from NASDAQ and Deregistration with SEC
January 21, 2026  |  quiverquant.comQ
Venus Concept Announces Intention to Voluntary Delist from Nasdaq and Deregister with SEC
January 21, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/01/21/3222676/0/en/venus-concept-announces-intention-to-voluntary-delist-from-nasdaq-and-deregister-with-sec.html
Top 3 Health Care Stocks You May Want To Dump In January
January 20, 2026  |  benzinga.comhttps://www.benzinga.com/trading-ideas/short-ideas/26/01/50002177/top-3-health-care-stocks-you-may-want-to-dump-in-january?utm_source=snapi
Venus Concept Surges 405% as Madryn Asset Management Secures 91% Stake
January 16, 2026  |  sohu.comS
Why is VERO stock up 300% today?
January 16, 2026  |  msn.comhttps://www.msn.com/en-us/money/markets/why-is-vero-stock-up-300-today/ar-AA1UmaR5
Venus Concept (VERO) Stock Explodes Over 300% As Majority Owner Takes Control
January 16, 2026  |  blockonomi.comhttps://blockonomi.com/venus-concept-vero-stock-explodes-over-300-as-majority-owner-takes-control/
Dr. Koray Erdoğan’s U.S.-Patented KE-Bot Sets a New Benchmark in Hair Transplantation
January 16, 2026  |  independent.co.ukI
Venus Concept Secures Short-Term Debt Relief Extension
January 15, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/VERO/pressreleases/36957839/venus-concept-secures-short-term-debt-relief-extension/
Hair Restoration Market 2025 Industry Growth Statistics, Revenue Projections, Future Trends, and Forecast to 2033
January 8, 2026  |  taiwannews.com.twT
Fans swear these at-home gadgets can make your hair grow — but do they really work?
December 4, 2025  |  msn.comhttps://www.msn.com/en-us/health/medical/fans-swear-these-at-home-gadgets-can-make-your-hair-grow-but-do-they-really-work/ar-AA1REVow
Venus Concept Amends Loan Agreement with Madryn Health
December 2, 2025  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/venus-concept-amends-loan-agreement-with-madryn-health/ar-AA1RAJFA
Venus Concept Faces Mixed Fortunes in Earnings Call
November 13, 2025  |  msn.comhttps://www.msn.com/en-us/money/companies/venus-concept-faces-mixed-fortunes-in-earnings-call/ar-AA1Qpp0W
Venus Concept Inc (VERO) Q3 2025 Earnings Call Highlights: Navigating Growth and Challenges ...
November 13, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/venus-concept-inc-vero-q3-190702106.html

New MarketBeat Followers Over Time

Top Headlines

View All Headlines
NVIDIA logo displayed on a computer chip surrounded by illuminated green circuit board traces.
NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
By Thomas Hughes | August 11, 2026
A quantum computing processor glows inside a gold-plated dilution refrigerator in a research laboratory.
The Quantum Race Is Heating Up—And 2 Small Players Stand Out
By Nathan Reiff | August 17, 2026
The Metals Company logo displayed over an image of polymetallic nodules on the seafloor with sea stars.
The Metals Company’s Big Bet Now Comes Down to a License
By Thomas Hughes | August 16, 2026
SoundHound AI logo displayed within a glowing orange ring against a dark background with light wave effects.
SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
By Thomas Hughes | August 10, 2026
Intuit logo displayed over a desk with a laptop, coffee mug, notebook, plant, and financial chart printout.
Intuit’s Earnings Reset May Be More Pivot Than Plunge
By Jeffrey Neal Johnson | August 28, 2026
Presbia stock logo

Presbia OTCMKTS:LENSF

$0.02 0.00 (0.00%)
As of 10/21/2022

Presbia PLC, an ophthalmic device company, develops and markets optical lens implants for treating presbyopia. The company provides the refractive lens for patient surgeries, as well as accessories for procedures. It primarily operates in the United States, South Korea, Australia, Italy, the Netherlands, Ireland, Canada, and Germany. The company was founded in 2014 and is headquartered in Dublin, Ireland.

Vicarious Surgical stock logo

Vicarious Surgical NYSE:RBOT

$0.04 0.00 (0.00%)
As of 09/4/2026 11:53 AM Eastern

Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Stagezero Life Sciences stock logo

Stagezero Life Sciences OTCMKTS:SZLSF

$0.0010 0.00 (0.00%)
As of 09/4/2026

StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe. Its proprietary platform technology is Sentinel Principle, which identifies RNA-based biomarkers from whole blood. The company's lead product is Aristotle, a mRNA-based multi-cancer panel test for for the detection of multiple discrete cancers from a single sample of blood. It also offers ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer; Prostate Health Index, a screening test for prostate cancer; BreastSentry, a test to determine a woman's risk for developing breast cancer; and COVID-19 Tests. The company is based in Richmond Hill, Canada.

Venus Concept stock logo

Venus Concept NASDAQ:VERO

$0.31 0.00 (0.00%)
As of 09/4/2026

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas